This SOP establishes the requirements for developing, maintaining, and annually updating the hazardous drugs (HD) list and assessment of risk—including identification of HDs per NIOSH and USP <800>, documentation of dosage forms, hazard categories, risks of exposure, containment strategies, and alternative handling practices—to ensure personnel safety, regulatory compliance, and safe compounding operations.